Form 4: Guardant Health Chief Legal Officer Reports Stock Transactions

John G. Saia, Chief Legal Officer of Guardant Health, Inc., reported the acquisition and disposal of company stock and restricted stock units on December 1, 2024.

Summary

• John G. Saia, the Chief Legal Officer of Guardant Health, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
• On December 1, 2024, Mr. Saia acquired 263 shares of common stock through the vesting of restricted stock units.
• Also on December 1, 2024, 138 shares were disposed of to cover tax withholding obligations related to the vesting of the restricted stock units.
• The price of the disposed shares was $35.61.
• Following these transactions, Mr. Saia beneficially owns 33,075 shares of Guardant Health common stock.

Sentiment

Score: 5

Explanation: This is a routine filing related to stock transactions by an executive, and does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing related to executive compensation and is common for publicly traded companies.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
• The vesting schedule of the restricted stock units is typical for executive compensation packages.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Transactions, Restricted Stock Units, Guardant Health, John G. Saia, Equity Securities